Carboplatin trials for Castration-Resistant Prostate Carcinoma

All Carboplatin trials · All Castration-Resistant Prostate Carcinoma trials

Phase breakdown

Recruiting trials studying Carboplatin for Castration-Resistant Prostate Carcinoma

• Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
  NCT06039371 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
  NCT06632977 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 108 locations
• Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
  NCT06470243 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 174 locations

Common questions

How many trials study Carboplatin for Castration-Resistant Prostate Carcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.